Gapping down
In reaction to earnings/guidance:
- SPLK -21.8%, GHLD -5.8%, DG -2.1%, SNOW -2%, COST -1.1%
Other news:
- VERI -16.5% (commenced public common stock offering)
- GLNG -6.7% (announced public offering of 11.0 mln common shares)
- DADA -6.7% (prices follow-on offering of 9 mln ADSs at $50.00 per ADS)
- JAZZ -6.5% (Jazz Pharma and PharmaMar report results of ATLANTIS Phase 3 study evaluating Zepzelca in combination with Doxorubicin did not meet primary endpoint)
- CDXS -4.7% (prices offering of 4,285,715 shares of its common stock at $17.50 per share)
- ORAN -3% (considering a conditional voluntary public takeover bid on Orange Belgium)
- OM -2.6% (prices secondary offering by selling shareholders of 4 mln shares of common stock at $53.00 per share)
- OSH -2.2% (prices offering of 5,632,430 shares of its common stock by certain selling stockholders at $46.00 per share)
- XP -1.6% (prices follow-on offering by co and selling shareholders of 31,654,894 Class A common shares at $39.00 per share)
- TWST -1.4% (prices offering of 2,802,272 shares of its common stock at $110.00 per share)